Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-26 6:24 pm Unchanged | 2025-06-24 | 13D | Organogenesis Holdings Inc. ORGO | Alan A. Ades | 22,319,836 17.600% | 0 (Unchanged) | Filing History |
| 2025-02-11 4:00 pm Purchase | 2024-12-31 | 13G | Organogenesis Holdings Inc. ORGO | Soleus Capital Master Fund, L.P. | 12,484,876 9.900% | 645,000 (+5.45%) | Filing History |
| 2025-01-13 5:05 pm Sale | 2025-01-09 | 13D | Organogenesis Holdings Inc. ORGO | Alan A. Ades | 22,319,836 17.800% | -1 (-0.00%) | Filing History |
| 2025-01-03 5:18 pm Unchanged | 2024-12-31 | 13D | Organogenesis Holdings Inc. ORGO | Alan A. Ades | 22,319,837 17.800% | 0 (Unchanged) | Filing History |
| 2024-11-19 4:05 pm Purchase | 2024-11-12 | 13D | Organogenesis Holdings Inc. ORGO | Avista Healthcare Partners III L.P. | 28,680,359 18.000% | 28,680,359 (New Position) | Filing History |
| 2024-11-14 8:09 pm Sale | 2024-11-12 | 13D | Organogenesis Holdings Inc. ORGO | Alan A. Ades | 22,319,837 17.800% | -4,055,909 (-15.38%) | Filing History |
| 2024-11-14 3:35 pm Purchase | 2024-09-30 | 13G | Organogenesis Holdings Inc. ORGO | Soleus Capital Master Fund, L.P. | 11,839,876 8.900% | 2,876,876 (+32.10%) | Filing History |
| 2024-02-09 4:09 pm Purchase | 2023-12-31 | 13G | Organogenesis Holdings Inc. ORGO | MORGAN STANLEY MS | 11,505,331 8.700% | 11,505,331 (New Position) | Filing History |
| 2024-02-02 09:54 am Purchase | 2023-12-31 | 13G | Organogenesis Holdings Inc. ORGO | Soleus Capital Master Fund, L.P. | 8,963,000 6.800% | 1,599,937 (+21.73%) | Filing History |
| 2023-04-06 09:29 am Sale | 2023-03-31 | 13G | Organogenesis Holdings Inc. ORGO | BlackRock Inc. BLK | 4,488,613 3.400% | -6,614,577 (-59.57%) | Filing History |
| 2023-02-14 08:22 am Purchase | 2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO | Soleus Capital Master Fund, L.P. | 7,363,063 5.600% | 737,000 (+11.12%) | Filing History |
| 2023-02-10 10:06 am Sale | 2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO | James E. Flynn | 0 0.000% | -8,456,876 (Position Closed) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO | BlackRock Inc. BLK | 11,103,190 8.500% | 2,863,358 (+34.75%) | Filing History |
| 2022-10-13 5:01 pm Purchase | 2022-10-11 | 13G | Organogenesis Holdings Inc. ORGO | Soleus Capital Master Fund, L.P. | 6,626,063 5.100% | 6,626,063 (New Position) | Filing History |
| 2022-02-11 4:12 pm Purchase | 2021-12-31 | 13G | Organogenesis Holdings Inc. ORGO | James E. Flynn | 8,456,876 6.570% | 762,513 (+9.91%) | Filing History |
| 2022-02-04 4:26 pm Purchase | 2021-12-31 | 13G | Organogenesis Holdings Inc. ORGO | BlackRock Inc. BLK | 8,239,832 6.400% | 8,239,832 (New Position) | Filing History |
| 2021-12-30 4:21 pm Unchanged | 2021-12-28 | 13D | Organogenesis Holdings Inc. ORGO | Alan A. Ades | 26,375,746 20.500% | 0 (Unchanged) | Filing History |
| 2021-12-17 5:01 pm Unchanged | 2021-12-15 | 13D | Organogenesis Holdings Inc. ORGO | Alan A. Ades | 26,375,746 20.500% | 0 (Unchanged) | Filing History |
| 2021-07-09 4:57 pm Purchase | 2021-06-29 | 13G | Organogenesis Holdings Inc. ORGO | James E. Flynn | 7,694,363 6.000% | 7,694,363 (New Position) | Filing History |
| 2021-05-28 9:28 pm Sale | 2021-05-27 | 13D | Organogenesis Holdings Inc. ORGO | Alan A. Ades | 26,375,746 20.600% | -3,887,500 (-12.85%) | Filing History |